Wanbury Limited Logo

Wanbury Limited

WANBURY.NS

(1.2)
Stock Price

217,79 INR

15.24% ROA

-423.58% ROE

15.75x PER

Market Cap.

8.254.007.975,00 INR

402.82% DER

0% Yield

9.33% NPM

Wanbury Limited Stock Analysis

Wanbury Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Wanbury Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-13.38x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (-509%), which means it has a small amount of debt compared to the ownership it holds

3 ROA

The stock's ROA (2.83%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 ROE

Negative ROE (-33.99%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-10.428), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Wanbury Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Wanbury Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Sell

Wanbury Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Wanbury Limited Revenue
Year Revenue Growth
2008 2.429.356.000
2009 4.725.859.000 48.59%
2010 3.821.796.000 -23.66%
2011 3.862.469.000 1.05%
2012 4.591.061.000 15.87%
2014 2.499.233.000 -83.7%
2015 4.232.616.000 40.95%
2016 4.366.282.000 3.06%
2017 3.681.179.000 -18.61%
2018 3.869.095.000 4.86%
2019 3.625.945.000 -6.71%
2020 3.871.025.000 6.33%
2021 5.072.355.000 23.68%
2022 4.996.469.000 -1.52%
2023 5.778.480.000 13.53%
2023 5.756.498.000 -0.38%
2024 5.244.328.000 -9.77%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Wanbury Limited Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 123.082.000 100%
2018 88.362.000 -39.29%
2019 42.494.000 -107.94%
2020 35.091.000 -21.1%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Wanbury Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 128.236.000
2009 249.519.000 48.61%
2010 248.854.000 -0.27%
2011 408.200.000 39.04%
2012 137.742.000 -196.35%
2014 58.106.000 -137.05%
2015 61.093.000 4.89%
2016 129.523.000 52.83%
2017 105.280.000 -23.03%
2018 133.682.000 21.25%
2019 170.264.000 21.49%
2020 142.098.000 -19.82%
2021 124.635.000 -14.01%
2022 132.432.000 5.89%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Wanbury Limited EBITDA
Year EBITDA Growth
2008 222.462.000
2009 598.964.000 62.86%
2010 -375.186.000 259.64%
2011 138.705.000 370.49%
2012 -311.357.000 144.55%
2014 289.852.000 207.42%
2015 341.411.000 15.1%
2016 266.083.000 -28.31%
2017 29.804.000 -792.78%
2018 170.055.000 82.47%
2019 690.487.000 75.37%
2020 240.360.000 -187.27%
2021 412.290.000 41.7%
2022 240.851.000 -71.18%
2023 724.000.000 66.73%
2023 700.022.000 -3.43%
2024 438.964.000 -59.47%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Wanbury Limited Gross Profit
Year Gross Profit Growth
2008 1.134.759.000
2009 2.471.572.000 54.09%
2010 1.730.327.000 -42.84%
2011 1.708.153.000 -1.3%
2012 2.089.752.000 18.26%
2014 1.298.692.000 -60.91%
2015 2.408.657.000 46.08%
2016 2.396.536.000 -0.51%
2017 1.752.947.000 -36.71%
2018 1.733.959.000 -1.1%
2019 1.679.625.000 -3.23%
2020 1.650.765.000 -1.75%
2021 2.013.629.000 18.02%
2022 1.970.574.000 -2.18%
2023 2.724.356.000 27.67%
2023 1.730.643.000 -57.42%
2024 1.456.524.000 -18.82%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Wanbury Limited Net Profit
Year Net Profit Growth
2008 -321.406.000
2009 84.146.000 481.96%
2010 -837.873.000 110.04%
2011 -388.943.000 -115.42%
2012 -872.294.000 55.41%
2014 32.038.000 2822.69%
2015 -71.464.000 144.83%
2016 -50.520.000 -41.46%
2017 -320.079.000 84.22%
2018 -248.477.000 -28.82%
2019 644.618.000 138.55%
2020 -126.057.000 611.37%
2021 814.739.000 115.47%
2022 -103.958.000 883.72%
2023 294.488.000 135.3%
2023 559.563.000 47.37%
2024 41.496.000 -1248.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Wanbury Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 -22
2009 6 520%
2010 -57 108.77%
2011 -26 -119.23%
2012 -50 48%
2014 2 5100%
2015 -4 133.33%
2016 -2 -50%
2017 -13 84.62%
2018 -10 -30%
2019 27 138.46%
2020 -5 620%
2021 25 120%
2022 -3 933.33%
2023 9 133.33%
2023 17 47.06%
2024 1 -1600%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Wanbury Limited Free Cashflow
Year Free Cashflow Growth
2008 482.572.000
2009 302.907.000 -59.31%
2010 -87.473.000 446.29%
2011 466.243.000 118.76%
2012 550.786.000 15.35%
2014 349.141.000 -57.75%
2015 252.480.000 -38.28%
2016 286.889.000 11.99%
2017 295.203.000 2.82%
2018 250.153.000 -18.01%
2019 363.027.000 31.09%
2020 90.756.750 -300%
2020 122.535.000 25.93%
2021 308.652.000 60.3%
2022 71.691.000 -330.53%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Wanbury Limited Operating Cashflow
Year Operating Cashflow Growth
2008 720.954.000
2009 416.052.000 -73.28%
2010 49.020.000 -748.74%
2011 706.573.000 93.06%
2012 741.213.000 4.67%
2014 401.670.000 -84.53%
2015 464.624.000 13.55%
2016 433.912.000 -7.08%
2017 323.646.000 -34.07%
2018 297.307.000 -8.86%
2019 441.333.000 32.63%
2020 110.333.250 -300%
2020 166.815.000 33.86%
2021 405.229.000 58.83%
2022 197.972.000 -104.69%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Wanbury Limited Capital Expenditure
Year Capital Expenditure Growth
2008 238.382.000
2009 113.145.000 -110.69%
2010 136.493.000 17.11%
2011 240.330.000 43.21%
2012 190.427.000 -26.21%
2014 52.529.000 -262.52%
2015 212.144.000 75.24%
2016 147.023.000 -44.29%
2017 28.443.000 -416.9%
2018 47.154.000 39.68%
2019 78.306.000 39.78%
2020 19.576.500 -300%
2020 44.280.000 55.79%
2021 96.577.000 54.15%
2022 126.281.000 23.52%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Wanbury Limited Equity
Year Equity Growth
2008 1.584.415.000
2009 1.924.508.000 17.67%
2010 1.503.701.000 -27.98%
2011 711.132.000 -111.45%
2012 -212.953.000 433.94%
2014 -1.672.783.000 87.27%
2015 -1.621.055.000 -3.19%
2016 -1.672.250.000 3.06%
2017 -1.846.829.000 9.45%
2018 -2.092.757.000 11.75%
2019 -1.434.531.000 -45.88%
2020 -1.562.436.000 8.19%
2021 -234.198.000 -567.14%
2022 -328.161.000 28.63%
2023 279.414.000 217.45%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Wanbury Limited Assets
Year Assets Growth
2008 8.336.655.000
2009 8.064.438.000 -3.38%
2010 8.071.310.000 0.09%
2011 8.109.884.000 0.48%
2012 7.729.058.000 -4.93%
2014 4.056.607.000 -90.53%
2015 3.834.830.000 -5.78%
2016 4.180.201.000 8.26%
2017 2.718.440.000 -53.77%
2018 2.860.473.000 4.97%
2019 2.786.924.000 -2.64%
2020 2.891.764.000 3.63%
2021 3.525.491.000 17.98%
2022 3.038.703.000 -16.02%
2023 3.434.931.000 11.54%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Wanbury Limited Liabilities
Year Liabilities Growth
2008 6.752.240.000
2009 6.139.930.000 -9.97%
2010 6.567.609.000 6.51%
2011 7.398.752.000 11.23%
2012 7.942.011.000 6.84%
2014 5.729.390.000 -38.62%
2015 5.455.885.000 -5.01%
2016 5.852.451.000 6.78%
2017 4.565.269.000 -28.2%
2018 4.953.230.000 7.83%
2019 4.221.455.000 -17.33%
2020 4.454.200.000 5.23%
2021 3.759.689.000 -18.47%
2022 3.366.864.000 -11.67%
2023 3.155.517.000 -6.7%

Wanbury Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
171.37
Net Income per Share
15.99
Price to Earning Ratio
15.75x
Price To Sales Ratio
1.47x
POCF Ratio
42.25
PFCF Ratio
42.32
Price to Book Ratio
29.49
EV to Sales
1.67
EV Over EBITDA
13.55
EV to Operating CashFlow
47.99
EV to FreeCashFlow
47.99
Earnings Yield
0.06
FreeCashFlow Yield
0.02
Market Cap
8,25 Bil.
Enterprise Value
9,36 Bil.
Graham Number
55.45
Graham NetNet
-67.62

Income Statement Metrics

Net Income per Share
15.99
Income Quality
0.35
ROE
-4.24
Return On Assets
0.15
Return On Capital Employed
0.43
Net Income per EBT
1
EBT Per Ebit
0.94
Ebit per Revenue
0.1
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.4
Operating Profit Margin
0.1
Pretax Profit Margin
0.09
Net Profit Margin
0.09

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
5.96
Free CashFlow per Share
5.96
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.4
Return on Tangible Assets
0.15
Days Sales Outstanding
58.25
Days Payables Outstanding
176.95
Days of Inventory on Hand
39.17
Receivables Turnover
6.27
Payables Turnover
2.06
Inventory Turnover
9.32
Capex per Share
0

Balance Sheet

Cash per Share
2,85
Book Value per Share
8,54
Tangible Book Value per Share
8.46
Shareholders Equity per Share
8.54
Interest Debt per Share
43.89
Debt to Equity
4.03
Debt to Assets
0.33
Net Debt to EBITDA
1.6
Current Ratio
0.74
Tangible Asset Value
0,28 Bil.
Net Current Asset Value
-1,56 Bil.
Invested Capital
1150093001
Working Capital
-0,55 Bil.
Intangibles to Total Assets
0
Average Receivables
0,45 Bil.
Average Payables
0,81 Bil.
Average Inventory
180116000
Debt to Market Cap
0.14

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Wanbury Limited Dividends
Year Dividends Growth
2007 2
2009 1 0%
2010 1 100%

Wanbury Limited Profile

About Wanbury Limited

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

CEO
Mr. Pradeep Patni
Employee
1.491
Address
BSEL Tech Park, B-Wing
Navi Mumbai, 400703

Wanbury Limited Executives & BODs

Wanbury Limited Executives & BODs
# Name Age
1 Mr. Vinod R. Verma
Chief Financial Officer
70
2 Mr. Jitendra Jayantilal Gandhi
Compliance Officer & Company Secretary
70
3 Mr. Krishnamoorthy Chandran
Vice Chairman
70
4 Mr. Mohan Kumar Rayana
Whole Time Director
70
5 Mr. Prakash Venkataraman B.E., MBA
Head of API Business
70
6 Mr. Pradeep Patni
Chief Executive Officer of India Formulation Business
70
7 Mr. Nanasaheb Gunjal
Senior Vice President of QA,QC & RA
70
8 Dr. Shireesh Bhalchandra Ambhaikar
President of Operations - API Business
70

Wanbury Limited Competitors

Venus Remedies Limited Logo
Venus Remedies Limited

VENUSREM.NS

(1.5)
Themis Medicare Limited Logo
Themis Medicare Limited

THEMISMED.NS

(3.8)
Vimta Labs Limited Logo
Vimta Labs Limited

VIMTALABS.NS

(2.5)
Vivimed Labs Limited Logo
Vivimed Labs Limited

VIVIMEDLAB.NS

(1.0)
Xpro India Limited Logo
Xpro India Limited

XPROINDIA.NS

(3.0)